首页> 外国专利> METHOD OF PLANNING SIMULTANEOUS USE OF PERITONEAL DIALYSIS AND HEMODIALYSIS, AND PLANNING APPARATUS FOR SIMULTANEOUS USE OF PERITONEAL DIALYSIS AND HEMODIALYSIS

METHOD OF PLANNING SIMULTANEOUS USE OF PERITONEAL DIALYSIS AND HEMODIALYSIS, AND PLANNING APPARATUS FOR SIMULTANEOUS USE OF PERITONEAL DIALYSIS AND HEMODIALYSIS

机译:规划同时使用腹膜透析和血液透析的方法,以及规划仪器同时使用腹膜透析和血液透析的方法

摘要

The present invention is a peritoneal dialysis and hemodialysis hybrid-remedy planning method using an index that is shared by both peritoneal dialysis and hemodialysis and indicates an effect of dialysis. To be specific, the index is M/C(0)/VB, which is obtained by dividing a ratio M/C(0)―where M is a removal amount of a solute for a fixed time period, and C(0) is a concentration of the solute in blood before the dialysis―by a patient's body fluid volume, VB. Conventionally, planning of a PD-HD hybrid remedy is very difficult since no prescription examination parameter shared between PD and HD is not known; however, the present invention is capable of representing the dialysis effect of PD and HD as an integrated sum, as shown above, and achieving concise and explicit PD and HD hybrid-remedy planning.
机译:本发明是一种腹膜透析和血液透析混合治疗计划方法,其使用由腹膜透析和血液透析两者共享并且指示透析效果的指标。具体而言,该指标为M / C(0)/ VB,其通过将比率M / C(0)除以其中M是固定时间段内的溶质去除量而得到,C(0)是透析前血液中溶质的浓度,取决于患者的体液量VB。传统上,PD-HD混合疗法的计划非常困难,因为尚不知道PD和HD之间共享的处方检查参数。然而,如上所述,本发明能够将PD和HD的透析效果表示为总和,并且实现简洁明了的PD和HD混合疗法计划。

著录项

  • 公开/公告号EP1623731A1

    专利类型

  • 公开/公告日2006-02-08

    原文格式PDF

  • 申请/专利权人 JMS CO. LTD.;

    申请/专利号EP20040733122

  • 发明设计人 HAMADA HIROYUKI;OKAMOTO MASAHIRO;

    申请日2004-05-14

  • 分类号A61M1/14;

  • 国家 EP

  • 入库时间 2022-08-21 21:29:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号